Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Refractory Cutaneous T Cell Lymphoma
NCT01132989Phase 2Unknown
- Sponsor
- Florida Academic Dermatology Centers
- Start
- May 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in cutaneous T-cell lymphoma (CTCL), sponsored by Florida Academic Dermatology Centers. Status: unknown.
02
Drugs
lenalidomide
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT01132989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01132989.